Jason F. Conaty
FDA guidance may ease path to biosimilar interchangeability
Focus on Regulation ·
FDA Proposes Rule Affecting Liability for Generic Drug Manufacturers
Focus on Regulation ·
FDA has announced rates for biosimilar user fees for FY 2013
Biosimilars Law Blog ·